Redesign Health launched a Growth Equity practice on November 13, 2026. The practice will make minority investments from Series A through pre-IPO. It will focus on healthcare IT, AI-enabled services, and clinical AI.
Investment track record
Redesign Health has invested in healthcare companies since its founding in 2018. It has already made opportunistic growth-stage investments, including Hippocratic AI. The new practice gives that activity a dedicated team and formal mandate.
New leadership
Richie Chaikof joined as Managing Director, Growth Equity. He brings experience from Optum Ventures and Bain Capital Ventures. Akhilesh Pathipati, a physician and former MVM partner, also joined the team.
Platform reach
The practice will draw on Redesign Health's investment expertise, technology capabilities, and health system relationships. An October merger with ARC Global and an agreement to acquire AVIA further expand those relationships. The company now connects to more than 100 health systems worldwide.
Founders and co-investors can contact the Growth Equity team at [email protected]. The practice sits within Redesign Health's broader investing team. The company is based in New York and has offices in Bengaluru, Boston, Los Angeles, Riyadh, and Tel Aviv.